Status:
COMPLETED
Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma
Lead Sponsor:
National Institute for Tuberculosis and Lung Diseases, Poland
Collaborating Sponsors:
University of Rzeszow
The Regional Public Hospital in Lesko, Poland
Conditions:
Asthma Chronic
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
A prospective, observational, interventional, single-blind study (blinded for a clinician in the field of inflammatory parameters). The aim of the study is evaluation of the usefulness of induced spu...
Detailed Description
Introduction Guidelines for the treatment of asthma recommend the use of the smallest dose of inhaled steroid (ICS), which allows to maintain control of the symptoms of the disease. The GINA 2006 guid...
Eligibility Criteria
Inclusion
- mild or moderate asthma with a stable course of at least 3 months:
- symptoms less than 4x per week,
- use of SABA below 3x a week,
- night awakening below 1x per week,
- FEV1\> 80% of predicted
- no dose change in ICS or use of systemic steroids from 3 months
- good adherence to treatment
Exclusion
- infection or exacerbation of asthma requiring the use of systemic steroids (or changes in the dose of inhaled steroids) in the last 3 months before the study
- other chronic lung diseases or general diseases affecting the respiratory system
- tobacco smoking
- FEV1 below 80% of the predicted value
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03788057
Start Date
February 1 2016
End Date
March 31 2019
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Regional Public Hospital in Lesko, Poland
Lesko, Poland, 38-600